Alphatec Stock Price, News & Analysis (NASDAQ:ATEC) $11.71 -0.24 (-2.01%) (As of 11/28/2023 ET) Add Compare Share Share Today's Range$11.46▼$11.9750-Day Range$8.89▼$13.1852-Week Range$8.66▼$19.14Volume1.40 million shsAverage Volume1.35 million shsMarket Capitalization$1.60 billionP/E RatioN/ADividend YieldN/APrice Target$21.86 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability Alphatec MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside86.7% Upside$21.86 Price TargetShort InterestBearish8.61% of Shares Sold ShortDividend StrengthN/ASustainability-1.67Upright™ Environmental ScoreNews Sentiment0.63Based on 2 Articles This WeekInsider TradingSelling Shares$3.27 M Sold Last QuarterProj. Earnings GrowthGrowingFrom ($1.44) to ($1.00) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.25 out of 5 starsMedical Sector332nd out of 949 stocksSurgical & Medical Instruments Industry44th out of 95 stocks 3.5 Analyst's Opinion Consensus RatingAlphatec has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 7 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $21.86, Alphatec has a forecasted upside of 86.7% from its current price of $11.71.Amount of Analyst CoverageAlphatec has only been the subject of 4 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted8.61% of the outstanding shares of Alphatec have been sold short.Short Interest Ratio / Days to CoverAlphatec has a short interest ratio ("days to cover") of 6.1.Change versus previous monthShort interest in Alphatec has recently increased by 1.29%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldAlphatec does not currently pay a dividend.Dividend GrowthAlphatec does not have a long track record of dividend growth. Previous Next 3.3 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreAlphatec has received a 37.18% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Cervical implants", "Medical screws", and "Lumbar spinal stenosis treatment instruments" products. See details.Environmental SustainabilityThe Environmental Impact score for Alphatec is -1.67. Previous Next 1.5 News and Social Media Coverage News SentimentAlphatec has a news sentiment score of 0.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.87 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Alphatec this week, compared to 2 articles on an average week.Search InterestOnly 3 people have searched for ATEC on MarketBeat in the last 30 days. This is a decrease of -40% compared to the previous 30 days.MarketBeat FollowsOnly 3 people have added Alphatec to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 5.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Alphatec insiders have sold 937.98% more of their company's stock than they have bought. Specifically, they have bought $315,000.00 in company stock and sold $3,269,645.00 in company stock.Percentage Held by Insiders29.12% of the stock of Alphatec is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions67.19% of the stock of Alphatec is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Alphatec are expected to grow in the coming year, from ($1.44) to ($1.00) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Alphatec is -7.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Alphatec is -7.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here About Alphatec Stock (NASDAQ:ATEC)Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. It manufactures and sells implants and instruments through third-party suppliers. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform; Sigma PTP Access and Patient Positioning System; split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; EOS imaging system that provides full-body imaging; spinal implants and fixation systems; and NanoTec and Calibrate PSX, as well as various standalone implants for height restoration and stabilization. It also provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix, a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM; AlphaGRAFT Demineralized Bone Matrix comprising demineralized human tissues; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives in the United States and internationally. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.Read More ATEC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ATEC Stock News HeadlinesNovember 28, 2023 | americanbankingnews.comAlphatec Holdings, Inc. (NASDAQ:ATEC) Receives $21.86 Consensus Target Price from BrokeragesNovember 12, 2023 | finance.yahoo.comWith 54% ownership of the shares, Alphatec Holdings, Inc. (NASDAQ:ATEC) is heavily dominated by institutional ownersNovember 28, 2023 | Autonomix (Ad)[Investor Alert] Potential Breakthrough Medical Tech Investment OpportunityAutonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comNovember 9, 2023 | seekingalpha.comAlphatec: Still Not Having My BackNovember 7, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Guardant Health (GH), Madrigal Pharmaceuticals (MDGL) and Alphatec Holdings (ATEC)November 7, 2023 | ca.sports.yahoo.comQ3 2023 Alphatec Holdings Inc Earnings CallNovember 7, 2023 | finance.yahoo.comAlphatec Holdings, Inc. (NASDAQ:ATEC) Q3 2023 Earnings Call TranscriptNovember 6, 2023 | seekingalpha.comAlphatec Holdings, Inc. 2023 Q3 - Results - Earnings Call PresentationNovember 28, 2023 | Autonomix (Ad)[Investor Alert] Potential Breakthrough Medical Tech Investment OpportunityAutonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comNovember 6, 2023 | msn.comAlphatec GAAP EPS of -$0.35November 6, 2023 | finance.yahoo.comATEC Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Adjusted EBITDA GuidanceNovember 6, 2023 | finance.yahoo.comAlphatec Holdings Inc (ATEC) Reports 32% Revenue Growth in Q3 2023, Raises Full Year EBITDA GuidanceNovember 5, 2023 | finance.yahoo.comATEC Nov 2023 10.000 callNovember 3, 2023 | msn.comAlphatec Q3 2023 Earnings PreviewOctober 31, 2023 | finance.yahoo.comATEC Equipped to Support Ramping Surgical Volume With Proceeds From Secondary OfferingOctober 27, 2023 | finance.yahoo.comATEC Announces Closing of Public Stock OfferingOctober 26, 2023 | marketwatch.comAlphatec Holdings Shares Fall Premarket After Offering PricedOctober 26, 2023 | msn.comAlphatec drops 15%, prices $150M stock offering at $10.50 per shareOctober 26, 2023 | markets.businessinsider.comWhy Alphatec Holdings Inc (ATEC) Stock Is FallingOctober 25, 2023 | finance.yahoo.comWhy Alphatec Holdings Stock Plunged TodayOctober 25, 2023 | benzinga.comWhy Alphatec (ATEC) Stock Is NosedivingOctober 24, 2023 | msn.comAlphatec commences proposed public offeringOctober 24, 2023 | marketwatch.comAlphatec Shares Fall 14% as Co. Commences $150M Public OfferingOctober 24, 2023 | finance.yahoo.comAlphatec Holdings, Inc. (L1Z1.F)October 20, 2023 | msn.comRoth MKM Initiates Coverage of Alphatec Holdings (ATEC) with Buy RecommendationOctober 20, 2023 | markets.businessinsider.comWhat 6 Analyst Ratings Have To Say About Alphatec HoldingsOctober 17, 2023 | finance.yahoo.comATEC Enhances Board with Renowned Spine ProwessSee More Headlines Receive ATEC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alphatec and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/06/2023Today11/28/2023Fiscal Year End12/31/2023Next Earnings (Estimated)2/27/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNASDAQ:ATEC CUSIP02081G10 CIK1350653 Webwww.atecspine.com Phone(760) 431-9286Fax800-922-1356Employees705Year Founded1990Price Target and Rating Average Stock Price Target$21.86 High Stock Price Target$32.00 Low Stock Price Target$16.00 Potential Upside/Downside+86.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)($1.51) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-152,150,000.00 Net Margins-38.32% Pretax Margin-38.43% Return on EquityN/A Return on Assets-28.98% Debt Debt-to-Equity RatioN/A Current Ratio2.25 Quick Ratio1.37 Sales & Book Value Annual Sales$350.87 million Price / Sales4.55 Cash FlowN/A Price / Cash FlowN/A Book Value($0.35) per share Price / Book-33.46Miscellaneous Outstanding Shares136,300,000Free Float96,610,000Market Cap$1.60 billion OptionableNot Optionable Beta1.35 Social Links 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Patrick S. Miles (Age 57)Executive Chairman, CEO & President Comp: $1.59MMr. J. Todd Koning (Age 50)Executive VP & CFO Comp: $815.29kMr. David P. Sponsel (Age 44)Executive Vice President of Sales Comp: $848.19kMr. Craig E. Hunsaker (Age 59)Executive VP of People and Culture Comp: $909.33kMr. Eric Dasso (Age 50)Executive Vice President of Adjunctive Technologies Comp: $1MMr. Tyson Eliot Marshall (Age 49)General Counsel & Corporate Secretary Mr. Ali Shorooghi (Age 37)Senior Vice President of Marketing Mr. Jonathan Allen (Age 63)Executive Vice President of Commercial Operations Mr. Scott Lish (Age 42)Senior Vice President of Research & Development Dr. Luiz PimentaChief Medical OfficerMore ExecutivesKey CompetitorsAtriCureNASDAQ:ATRCSurmodicsNASDAQ:SRDXOrthofix MedicalNASDAQ:OFIXIntegra LifeSciencesNASDAQ:IARTGlobus MedicalNYSE:GMEDView All CompetitorsInsiders & InstitutionsWalleye Capital LLCBought 92,174 shares on 11/21/2023Ownership: 0.584%Invst LLCBought 20,000 shares on 11/21/2023Ownership: 0.112%Walleye Trading LLCBought 2,375 shares on 11/21/2023Ownership: 0.037%Comerica BankBought 2,792 shares on 11/21/2023Ownership: 0.002%Spouting Rock Asset Management LLCBought 1,094 shares on 11/16/2023Ownership: 0.010%View All Insider TransactionsView All Institutional Transactions ATEC Stock Analysis - Frequently Asked Questions Should I buy or sell Alphatec stock right now? 7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Alphatec in the last year. There are currently 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ATEC shares. View ATEC analyst ratings or view top-rated stocks. What is Alphatec's stock price target for 2024? 7 analysts have issued 12-month price objectives for Alphatec's shares. Their ATEC share price targets range from $16.00 to $32.00. On average, they expect the company's stock price to reach $21.86 in the next year. This suggests a possible upside of 86.7% from the stock's current price. View analysts price targets for ATEC or view top-rated stocks among Wall Street analysts. How have ATEC shares performed in 2023? Alphatec's stock was trading at $12.35 at the start of the year. Since then, ATEC shares have decreased by 5.2% and is now trading at $11.71. View the best growth stocks for 2023 here. When is Alphatec's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024. View our ATEC earnings forecast. How were Alphatec's earnings last quarter? Alphatec Holdings, Inc. (NASDAQ:ATEC) released its quarterly earnings results on Monday, November, 6th. The medical technology company reported ($0.35) EPS for the quarter, missing the consensus estimate of ($0.30) by $0.05. The medical technology company earned $118.26 million during the quarter, compared to analyst estimates of $115.30 million. What ETFs hold Alphatec's stock? ETFs with the largest weight of Alphatec (NASDAQ:ATEC) stock in their portfolio include Jacob Forward ETF (JFWD), Innovator IBD 50 ETF (FFTY), SPDR S&P Health Care Equipment ETF (XHE) and Invesco Dorsey Wright Healthcare Momentum ETF (PTH).First Trust Nasdaq Lux Digital Health Solutions ETF (EKG). What guidance has Alphatec issued on next quarter's earnings? Alphatec issued an update on its third quarter 2023 earnings guidance on Monday, October, 16th. The company provided EPS guidance of for the period. The company issued revenue guidance of $117.70 million-$118.50 million, compared to the consensus revenue estimate of $111.78 million. What is Pat Miles' approval rating as Alphatec's CEO? 19 employees have rated Alphatec Chief Executive Officer Pat Miles on Glassdoor.com. Pat Miles has an approval rating of 72% among the company's employees. 63.0% of employees surveyed would recommend working at Alphatec to a friend. What other stocks do shareholders of Alphatec own? Based on aggregate information from My MarketBeat watchlists, some companies that other Alphatec investors own include Macrocure Ltd. - Ordinary Share (MCUR), LinnCo (LNCOQ), California Resources (CRC), Sorrento Therapeutics (SRNE), Catalyst Pharmaceuticals (CPRX), (GBSN) (GBSN), Idera Pharmaceuticals (IDRA), Athersys (ATHX), Anavex Life Sciences (AVXL) and BioCryst Pharmaceuticals (BCRX). Who are Alphatec's major shareholders? Alphatec's stock is owned by many different retail and institutional investors. Top institutional investors include Fred Alger Management LLC (1.71%), Assenagon Asset Management S.A. (1.32%), Royal Bank of Canada (1.14%), abrdn plc (1.15%), New York State Common Retirement Fund (0.73%) and Walleye Capital LLC (0.58%). Insiders that own company stock include Craig E Hunsaker, David H Mowry, David M Demski, David R Pelizzon, David Sponsel, Elizabeth Ann Altman, Evan Bakst, James L L Tullis, James L L Tullis, Jason Hochberg, Jeffrey G Black, Jennifer N Pritzker, Jennifer N Pritzker, John Todd Koning, L-5 Healthcare Partners, Llc, Mortimer Berkowitz III, Patrick Miles, Paul Segal and Scott Lish. View institutional ownership trends. How do I buy shares of Alphatec? Shares of ATEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:ATEC) was last updated on 11/28/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alphatec Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.